Hi AD,
Your point regarding failed trials in the past is interesting, I asked Ai Chat and a list of 10 failed clinical trials quickly appeared. Roach. Novartis and Biogen amounts them.
I think those 3 would have a wealth of research regarding the the potential market etc etc, still on their hard drives making their due diligence easier and quicker. I also think they would have a very good idea of what may qualify for ODD status. Remember ODD is not a clinical trial so there is not the same scrutiny on efficacy.
While I think a quick resolution is possible, my idea of quick is mid year not next week. I'm possibly also a bit more cautious on the final price than some on here. But hey if others who are more bullish prove to be correct that's cool.
Cheers
GLTAH
- Forums
- ASX - By Stock
- PAA
- Ann: Application for quotation of securities - PAA
Ann: Application for quotation of securities - PAA, page-48
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.90M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 107000 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.5¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 107000 | 0.225 |
5 | 246816 | 0.220 |
3 | 111200 | 0.215 |
5 | 281446 | 0.210 |
4 | 321081 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.215 | 20000 | 1 |
0.220 | 89858 | 3 |
0.225 | 121000 | 4 |
0.230 | 166213 | 5 |
0.240 | 234170 | 4 |
Last trade - 09.58am 16/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online